• Facebook
  • Instagram
  • Youtube
  • My Account
  • Cart
  • Checkout
Insulin Pump Emergency Line: 07775 642 239 Office hours Phone: 01926 833 273
  • 0Shopping Cart
Advanced Therapeutics (UK) Ltd
  • Home
    • About Us
    • Cart
    • Privacy Policy
    • Contact Us
  • Our Products
    • Dana Diabecare i Insulin Pump
    • DANA Diabecare RS Insulin Pump
    • Dana RS Training Videos
    • Infusion Sets
    • MedAngel One
  • Hybrid Closed Loop Therapy
    • CamAPS® FX
    • CamAPS FX in the News
  • Insulin Pump Therapy
    • Dana RS Training Videos
    • Dana RS Diabecare Field Safety Notice
    • How do I get a pump?
    • What are the Benefits?
    • Is an Insulin pump for you?
    • Everyday Life with a pump
    • More about Insulin Treatment for Type 1 Diabetes
  • Healthcare Professionals
    • Benefits of Insulin Pump Therapy
    • History of Insulin Pump Therapy
    • NICE Guidelines & Funding for Insulin Pump Therapy
    • NICE Guidelines & Funding for Glucose Monitoring
    • Clinical Research/Papers/Abstracts
    • Government Publications
    • Contact Us
  • Search
  • Menu Menu

Blood Glucose, HbA1c and insulin requirment under MDI and CSII

You are here: Home1 / Clinical Research/Papers/Abstracts2 / Blood Glucose, HbA1c and insulin requirment under MDI and CSII

Our Address

Advanced Therapeutics (UK) Ltd
17-19 Athena Court, Athena Drive, Tachbrook Park,
WARWICK, UK, CV34 6RT
Email: info@advancedtherapeuticsuk.com

Company Details

Registered in England No 5517697
Registered Office: 12 Payton Street
Stratford-Upon-Avon
CV37 6UA
Vat Registration No: 866 5731 85
Privacy policy

Get In Touch

Orders & Technical Queries
Mon - Fri 9:30am - 5:30pm
01926 833 273
Mon - Sun Technical Support Emergencies
07775 642 239
Delivery Information
Returns Policy
© Copyright - Advanced Therapeutics
  • Home
  • Our Products
  • Hybrid Closed Loop Therapy
  • Insulin Pump Therapy
  • Healthcare Professionals
Scroll to top